Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine in Ulcerative Colitis
NCT02365480Phase 1Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial in colorectal cancer (CRC) comparing Berberine Chloride with Placebo (2 arms). Primary endpoints: Number of Participants With Clinical Toxicity Using CTCAE v4.0 and Number of Participants With Organ Toxicity Using CTCAE v4.0 at Day 90. Started Jun 2016; status: completed.
02
Drugs
berberine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02365480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365480.